(Q34553378)

3 August 2017

Trichostatin A restores Apaf-1 function in chemoresistant ovarian cancer cells (English)

1 reference

3 August 2017

1 reference

Lijun Tan

1

1 reference

3 August 2017

Roland P Kwok

2

1 reference

3 August 2017

Abhishek Shukla

3

1 reference

3 August 2017

Malti Kshirsagar

4

1 reference

3 August 2017

Lili Zhao

5

1 reference

3 August 2017

Anthony W Opipari

6

1 reference

3 August 2017

J Rebecca Liu

7

1 reference

3 August 2017

language of work or name

English

0 references

publication date

5 October 2010

1 reference

3 August 2017

1 reference

3 August 2017

117

1 reference

3 August 2017

4

1 reference

3 August 2017

784-794

1 reference

Rational combinations using HDAC inhibitors

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033976

Enhancing the apoptotic and therapeutic effects of HDAC inhibitors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033976

7 July 2018

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033976

Anticancer activities of histone deacetylase inhibitors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033976

The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033976

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033976

Histone deacetylase inhibitors: a review of their clinical status as antineoplastic agents.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033976

Methylation silencing of the Apaf-1 gene in acute leukemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033976

Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033976

Plasma membrane sequestration of apoptotic protease-activating factor-1 in human B-lymphoma cells: a novel mechanism of chemoresistance.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033976

Apoptosome dysfunction in human cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033976

Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033976

Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033976

Apaf-1 overexpression partially overcomes apoptotic resistance in a cisplatin-selected HeLa cell line

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033976

The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033976

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033976

Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction

7 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20925046

12 December 2020

inferred from PubMed ID database lookup

The predictive value of apoptosis protease-activating factor 1 in rectal tumors treated with preoperative, high-dose-rate brachytherapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20925046

12 December 2020

inferred from PubMed ID database lookup

Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20925046

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1002/CNCR.25649

1 reference

release_dtpqlwbmajawhb6qjss34k24ki

3 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dtpqlwbmajawhb6qjss34k24ki

24 November 2022

mapped directly with Wikidata item

PMCID

3033976

1 reference

3 August 2017

1 reference